Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The quest to understand and slow disease ...
The following is a summary of “A qualitative study on the experiences of autologous haematopoietic stem cell transplant for Multiple Sclerosis,” published in the November 2024 issue of Neurology by ...
The following is a summary of “Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration Gap,” published in the November 2024 issue of ...
(Science) A case report assessed the effect of continuous exposure to ofatumumab (Kesimpta) during pregnancy in a patient ...
The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...
A higher burden of comorbidities, including 2 or more cardiometabolic diseases, is tied to greater MS disease activity in patients.
An ordinal score incorporating eight independent binary clinical variables shows good performance for predicting seizure freedom one year after surgery for mesial temporal lobe epilepsy.
SEC recommends marketing approval for Dr Reddy's SPMS drug Siponimod tablets: Gireesh Babu, New Delhi Friday, November 8, 2024, 08:00 Hrs [IST] The Subject Expert Committee (SEC), ...
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control (CDSCO) has granted ...
President and CEO: Jake Allen - Goldman Sachs: Sung Ji Nam - Scotiabank: Kyle Mikson - Canaccord Genuity: Puneet Souda - ...
Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...